Effect of the anxiolytic fabomotizol on the time parameters of atrial depolarization in the acute phase of myocardial infarction

The aim of the work is to study the effect of the anxiolytic fabomotizole (15 mg/kg, i.v.) on atrial depolarization in the acute phase of myocardial infarction using the method of synchronous multichannel cardioelectrochronotopography. Synchronous multichannel cardioelectrochronotopography was used to study the sequence of depolarization of the atrial epicardium in outbred rats during the acute phase of myocardial infarction caused by ligation of the anterior branch of the left coronary artery with simultaneous administration of the σ1-receptor agonist fabomotizole. Significant differences in the temporal characteristics of atrial depolarization in the acute phase of myocardial infarction were revealed in control animals and animals treated with fabomotizol. In rats against the background of fabomotizol, changes in the time of the onset of epicardial depolarization, the transition of the excitation wave from the right to the left atrium, and the end of depolarization, compared with the initial state, occur by the 5th minute after the ligation of the coronary vessel; in the process of further development of acute myocardial infarction, changes in time parameters are not observed .In animals of the control group, changes in the time parameters of atrial depolarization after coronary vessel ligation develop by 10 minutes after ligation and continue to change as acute myocardial infarction develops. Anxiolytic fabomotizol in the most acute phase of myocardial infarction changes the time parameters of atrial depolarization, preventing the development of atrial fibrillation.

1. Sugiura T, Iwasaka T, Takahashi N, et al. Atrial fibrillation in inferior wall Q-wave acute myocardial infarction. Am J Cardiol. 1991;67(13):1135–1136. DOI: 10.1016/0002-9149(91)90879-p.

2. Tilling L, Clapp B. Atrial fibrillation in myocardial infarction: predictors and prognosis. Int J Clin Pract. 2009;63(5):680–682. DOI: 10.1111/j.1742-1241.2009.02061.x.

3. Shevchenko AS, Schukina EV, Alyoshechkin PA Influence of electrical activity of the myocardium on the formation of atrial fibrillation in patients in the postinfarction period. Challenges in Modern Medicine. 2022;45(2):141–151. (In Russ). DOI: 10.52575/2687-0940-2022-45-2-141-151.

4. Schnabel RB, Yin X, Gona P, et al. 50 year trends in atrial fibrillation prevalence, incidence, risk factors, and mortality in the Framingham Heart Study: a cohort study. The Lancet. 2015;386(9989):154–162. DOI: 10.1016/S0140-6736(14)61774-8.

5. Borodashkina SY, Protasov KV. Clinical and pathogenetic features of myocardial infarction in patients with atrial fibrillation. Siberian Medical Review. 2020;(5):31–39. (In Russ). DOI: 10.20333/2500136-2020-5-31-39.

6. Bahouth F, Mutlak D, Furman M, et al. Relationship of functional mitral regurgitation to new-onset atrial fibrillation in acute myocardial infarction. Heart. 2010;96(9):683–688. DOI: 10.1136/hrt.2009.183822.

7. Kabell G, Buchanan LV, Gibson JK, et al. Effects of adenosine on atrial refractoriness and arrhythmias. Cardiovasc Res. 1994;28(9):1385–1389. DOI: 10.1093/cvr/28.9.1385.

8. Kryzhanovskii SA, Stolyaruck VN, Vititnova MB, Tsorin IB, Seredenin SB. Pleiotropic (cardiotropic) effects of the anxiolytic afobazole. Therapist. 2012;(1):32–40. (In Russ).

9. Kryzhanovskii SA, Sorokina AV, Stolyaruck VN, Vititnova MB, Miroshkina IA, Tsorin IB, Durnev AD, Seredenin SB. Study of anti-ischemic effect of afobazole in experimental myocardial infarction. Bull Experim Biol Med. 2010;150(9):284–287. (In Russ). DOI: 10.1007/s10517-011-1131-4.

10. Tsorin IB, Barchukov VV, Vititnova MB, Kryzhanovskii SA, Seredenin SB. Anti-ischemic activity of fabomotizole hydrochloride under conditions of endothelial dysfunction. Bull Experim Biol Med. 2019;167(5):634–636. (In Russ). DOI: 10.1007/s10517-019-04586-x.

11. Stolyaruk VN, Vititnova MB, Kryzhanovskii SA. Investigation of Afobasol Effects on a Model of Reperfusion Arrhythmias. Vestnik Rossiiskoi Akademii Meditsinskikh Nauk. 2010;(4):41–45. (In Russ).

12. Stolyaruk VN, Vititnova MB, Tsorin IB, Kryzhanovskii SA. Evaluation of Afobasol Efficiency on a Model of Vagotonic Atrial Fibrillation. Vestnik Rossiiskoi Akademii Meditsinskikh Nauk. 2010;(4):49–52. (In Russ).

13. Stolyaruk VN, Vititnova MB, Tsorin IB, Kryzhanovskii SA. Study of the antifibrillatory activity of afobazole in animals with intact and denervated myocardium. Vestnik Rossiiskoi Akademii Meditsinskikh Nauk. 2010;(4):45–48. (In Russ).

14. Liu X, Qu C, Yang H, et al. Chronic stimulation of the Sigma-1 receptor ameliorates autonomic nerve dysfunction and atrial fibrillation susceptibility in a rat model of depression. Am J Physiol Heart Circ Physiol. 2018;315(6): H1521-H1531. DOI: 10.1152/ajpheart.00607.2017.